Experiences and Perceptions of Colonoscopy and New Technologies

February 9, 2021 updated by: The Leeds Teaching Hospitals NHS Trust

Patient and Endoscopists' Experiences and Perceptions of Colonoscopy and New Technologies in Colonoscopy

Bowel cancer is the 3rd most common cancer in males and females. Most bowel cancers develop from precancerous polyps in the bowel. Colonoscopy can detect and remove these polyps, thereby reducing the risk of developing bowel cancer. However, colonoscopy is an invasive procedure with inherent risk, and can be both uncomfortable and embarrassing to undergo. The risks and numerous other barriers often mean colonoscopy, and cancer preventing polyp removal, is not performed.

The investigators aim to start the first in-human feasibility clinical investigation of a robotic magnetic colonoscope in 2021. The new device aims to reduce the discomfort and risk associated with colonoscopy. As part of the patient and end user involvement aspect of the project the investigators aim to perform a mixed methodology inductive type research project exploring experiences of colonoscopy for patient and endoscopists.

The study will follow an exploratory mixed methodology format with two parallel work-streams for patients and endoscopists. Each work-stream will consisting of a focus groups (1-2 for each patients and endoscopists), followed by 20 endoscopist and 30 patient in-depth interviews, then an online questionnaire. Each stage will be thematically analysed to form the semi-structured questions for the next stage. The target population will be endoscopists who perform colonoscopy and people who have undergone, or refused to undergo, a colonoscopy. Focus groups will be performed in groups of 6-10 participants, and both interview and focus groups will be performed via video/teleconferencing.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patient invitations will be sent out to those on the emailing list of Crohns and Colitis UK, Bowel Cancer UK, Bowel Research UK and advertised on social media, to target populations likely to have experience in colonoscopy and across a variety of indications. Advertising posters will be placed in the outpatient and endoscopy departments of Leeds Teaching Hospitals NHS Trust.

Endoscopist invitations will be via emailing lists to JAG and ACPGBI members, Gastroenterology trainees and nurse endoscopist groups and advertised on social media, attempting to get a representation of various specialties and roles involved in colonoscopy, such as Gastroenterologists (Consultants and trainees), Surgeons and non-medical endoscopists.

Description

Inclusion Criteria:

One of:

  • undergone a colonoscopy
  • offered a colonoscopy but declined
  • perform or training to perform colonoscopy

Exclusion Criteria:

  • Non-English speaking
  • Unable to comply with any study requirements
  • New or ongoing diagnosis of bowel cancer

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients
Patients who have undergone or refused to undergo colonoscopy
Exploration of patient and endoscopists experiences of colonoscopy.
Endoscopists
Endoscopists who perform or are training to perform colonoscopy
Exploration of patient and endoscopists experiences of colonoscopy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient participant reported experience of colonoscopy - focus group
Time Frame: 1 year
Descriptive reporting on thematic analysis of a focus group involving patients exploring their experience of colonoscopy.
1 year
Patient participant reported experience of colonoscopy - interviews
Time Frame: 1 year
Descriptive reporting on thematic analysis following interviews of patients exploring their experience of colonoscopy.
1 year
Patient participant reported barriers to colonoscopy - focus group
Time Frame: 1 year
Descriptive reporting on thematic analysis following a focus groups involving patients exploring the barriers to colonoscopy.
1 year
Patient participant reported barriers to colonoscopy - interviews
Time Frame: 1 year
Descriptive reporting on thematic analysis following interviews of patients exploring the barriers to colonoscopy.
1 year
Colonoscopist participant perceptions of the patient experience of colonoscopy - focus group
Time Frame: 1 year
Descriptive reporting on thematic analysis of a focus groups involving colonoscopists exploring what they feel to be important patient experience measures in colonoscopy.
1 year
Colonoscopist participant perceptions of the patient experience of colonoscopy - interviews
Time Frame: 1 year
Descriptive reporting on thematic analysis of interviews of colonoscopists exploring what they feel to be important patient experience measures in colonoscopy.
1 year
Colonoscopist participant perceptions of the patient barriers to colonoscopy - focus group
Time Frame: 1 year
Descriptive reporting on thematic analysis of a focus group involving colonoscopists exploring what they feel to be important barriers to colonoscopy for patients.
1 year
Colonoscopist participant perceptions of the patient barriers to colonoscopy - interviews
Time Frame: 1 year
Descriptive reporting on thematic analysis of interviews of colonoscopists exploring what they feel to be important barriers to colonoscopy for patients.
1 year
PREMs patient participant questionnaire
Time Frame: 1 year
Level of importance given to the reported patient experience measures and barriers (as developed from the interviews and focus groups), assessed by Likert style questions.
1 year
PREMs colonoscopist participant questionnaire
Time Frame: 1 year
Perceived level of importance given to the reported patient experience measures and barriers (as developed from the interviews and focus groups), assessed by Likert style questions.
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient participants thoughts and feelings about robotic colonoscopy - focus group
Time Frame: 1 year
Descriptive reporting following thematic analysis of a focus group exploring patients' thoughts and feeling on a new colonoscopy technology - a magnetic robotic colonoscope.
1 year
Patient participants thoughts and feelings about robotic colonoscopy - interview
Time Frame: 1 year
Descriptive reporting following thematic analysis of interviews exploring patients' thoughts and feeling on a new colonoscopy technology - a magnetic robotic colonoscope.
1 year
Patient participants thoughts and feelings about artificial intelligence - focus group
Time Frame: 1 year
Descriptive reporting following thematic analysis of a focus group exploring patients' thoughts and feeling on a artificial intelligence in endoscopy
1 year
Patient participants thoughts and feelings about artificial intelligence - interviews
Time Frame: 1 year
Descriptive reporting following thematic analysis of interviews exploring patients' thoughts and feeling on a artificial intelligence in endoscopy
1 year
Colonoscopist participants thoughts and feelings about robotic colonoscopy - focus group
Time Frame: 1 year
Descriptive reporting following thematic analysis of a focus group exploring colonoscopists' thoughts and feeling on a new colonoscopy technology - a magnetic robotic colonoscope.
1 year
Colonoscopist participants thoughts and feelings about robotic colonoscopy - interviews
Time Frame: 1 year
Descriptive reporting following thematic analysis of interviews exploring colonoscopists' thoughts and feeling on a new colonoscopy technology - a magnetic robotic colonoscope.
1 year
Colonoscopist participants thoughts and feelings about artificial intelligence - focus groups
Time Frame: 1 year
Descriptive reporting following thematic analysis of a focus group exploring colonoscopists' thoughts and feeling on a artificial intelligence in endoscopy.
1 year
Colonoscopist participants thoughts and feelings about artificial intelligence - interviews
Time Frame: 1 year
Descriptive reporting following thematic analysis of interviews exploring colonoscopists' thoughts and feeling on a artificial intelligence in endoscopy.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 1, 2021

Primary Completion (Anticipated)

December 31, 2021

Study Completion (Anticipated)

December 31, 2021

Study Registration Dates

First Submitted

January 27, 2021

First Submitted That Met QC Criteria

February 9, 2021

First Posted (Actual)

February 10, 2021

Study Record Updates

Last Update Posted (Actual)

February 10, 2021

Last Update Submitted That Met QC Criteria

February 9, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

If possible to suitably anonymise, exerts from the focus group and interview transcripts will be made available.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bowel Cancer

Clinical Trials on Patient and endoscopist reported experience

Subscribe